China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A prospective, single-arm clinical study of IDH1 inhibitor combined with Essentiale in ... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Simplified Geriatric Assessment-Based Prediction of 90-Day Major Adverse Postoperative ... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Using computer simulation technology to screen suitable dietary regimens for population... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A randomized controlled trial evaluating the accuracy of implant placement during autom... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Construction of a Psycho-Cardiac Risk Warning System and Sex Difference Comparative Stu... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Quantitative measurement of bite force under dynamic functional conditions'. The follow... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Personalized Recommendation and Verification of PCA Analgesia Scheme After Abdominal Su... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Development of a Movement-Evoked Pain Management Protocol and Its Health Economic Evalu... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Clinical study on the combination of botulinum toxin and polidocanol compared to repeat... Read More
China, Nov. 10 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study of Single Ascending Doses and Multiple Dosing of the Novel Lp-PLA2 Inhibitor SR... Read More